2019
DOI: 10.21037/tlcr.2019.08.18
|View full text |Cite
|
Sign up to set email alerts
|

Elemental and mutational analysis of lung tissue in lung adenocarcinoma patients

Abstract: Background: This study aimed to observe the association between trace element concentrations in lung tissue from lung adenocarcinoma cancer (LADC) patients and mutations in the epidermal growth factor receptor (EGFR) and KRAS genes.Methods: LADC patients who had undergone lung resection were included in this study. Furthermore, twenty patients without lung cancer were included in this study as the control group. Samples were separately collected from both tumor and peritumor tissues. The mutational status was … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 44 publications
0
4
0
Order By: Relevance
“…A significant number of publications cover the involvement of trace and major elements in the process of carcinogenesis. The differences in elemental accumulation between healthy and neoplastic tissues are observed in the case of various types of tumors [ 23 , 24 , 25 , 26 ]. They may result, among others, from an increased demand for some elements during the tumor development, which may, in turn, be associated with the changed metabolism of tumor cells or their higher proliferation ability [ 27 , 28 , 29 , 30 ].…”
Section: Discussionmentioning
confidence: 99%
“…A significant number of publications cover the involvement of trace and major elements in the process of carcinogenesis. The differences in elemental accumulation between healthy and neoplastic tissues are observed in the case of various types of tumors [ 23 , 24 , 25 , 26 ]. They may result, among others, from an increased demand for some elements during the tumor development, which may, in turn, be associated with the changed metabolism of tumor cells or their higher proliferation ability [ 27 , 28 , 29 , 30 ].…”
Section: Discussionmentioning
confidence: 99%
“…Lung cancer is the most common and deadly malignant tumor in humans with an incidence and mortality rate of 11.6% and 18.4% respectively (1). Non-small cell lung cancers (NSCLC) are the most common type of lung cancer, of which lung adenocarcinoma is the main pathologic type, accounting for 40% of lung cancer (2). Most lung adenocarcinoma is identified in the late stage, and the 5-year survival rate is low (3), possibly because there is currently no specific biomarker to facilitate early diagnosis and prognosis prediction (3).…”
Section: Introductionmentioning
confidence: 99%
“…Lung cancer is the main reason for cancer‐related deaths, and the total deaths have been predicted to be 1.8 million (18%) [ 1 ]. Non‐small cell lung cancer (NSCLC) accounts for almost 85% of lung cancer cases [ 2 ], and lung adenocarcinoma (LUAD) serves as the main pathologic type (taking up 40%) of NSCLC [ 3 ]. Despite there're significant advancements in targeted therapies and immunotherapy, low response rates and drug resistance remain major clinical factors affecting prognosis [ 4 ].…”
Section: Introductionmentioning
confidence: 99%